Philadelphia, PA — July 2, 2018

With the passage into law of the new California Consumer Privacy Act, businesses now face the daunting task of rethinking their entire approach to managing consumer data. The law requires companies to disclose, to any consumer who asks, exactly what personal information has been collected, where else this data has been shared and, if asked, to comply with any request for it to be deleted. HealthVerity, Inc., a leader in cloud solutions for networked data, offers two platforms to address this new era in consumer privacy by which businesses will need to abide – HealthVerity Census and HealthVerity Consent.

HealthVerity Census solves the challenging problem of consolidating identities across enterprise datasets through a proven de-identification and matching service. By attributing a unique identity token, the HealthVerity ID, to each individual, enterprises can now securely and accurately de-identify consumer data in a HIPAA-compliant manner, consistent with the requirements of the new California law. HealthVerity Census can be deployed internally between an enterprises’ own disparate datasets and in combination with partners to create interoperability across an entire data ecosystem.

Recently launched within a top 10 pharmaceutical manufacturer, HealthVerity Consent is an enterprise-class platform that leverages blockchain to aggregate and manage consumer data use permissions. The solution utilizes smart contracts to communicate additions, changes and current status of those preferences. Companies are able to seamlessly and efficiently manage all consumer consents and permissions across a variety of source systems and provide real-time unified management of consumer consent necessary to support evolving data privacy needs. HealthVerity Consent ensures regulatory compliance by establishing a shared, immutable record of all the consumer consent transactions that take place within an enterprise, enabling only permissioned parties access to trusted information permitted data use in real time.

“Data privacy compliance and consumer consent are requirements that are no longer limited to just healthcare entities,” said Andrew Kress, CEO of HealthVerity. “Businesses across all industries will now need a reliable method to quickly access and determine whether a consumer has allowed their personal data to be used for a particular application. As a leader in blockchain for healthcare, we are leveraging our extensive experience in healthcare data privacy to deliver proven technologies that accomplish this standard for customers.”

PHILADELPHIA, PA — May 4, 2017 — HealthVerity, Inc., the leading cloud platform for the discovery, licensing and linking of broad scale healthcare data, today announced it has secured $10 million in Series B financing led by Flare Capital Partners and Greycroft Partners with participation from Foresite Capital and additional strategic healthcare investors.  HealthVerity will use the financing to fund continued expansion of its healthcare data ecosystem, advanced privacy solutions and proven data interoperability technologies.

HealthVerity Marketplace now offers linkable HIPAA-compliant de-identified healthcare data on more than 300 million individuals in the United States from over thirty national healthcare data suppliers providing medical claims, prescription claims, lab results, electronic medical records and other significant data types.  The company’s platform includes powerful self-service tools that enable users to build custom datasets by understanding and selecting relevant data sources, identifying counts of target patients and exploring longitudinality across multiple sources.  HealthVerity Marketplace further supports simplified data licensing that eliminates many of the industry’s challenges in delivering the right data at the right time for advanced analytics and patient insights.

“HealthVerity Marketplace is delivering transparency and open access for healthcare data that is transforming the way clients source key data for analytics,” said Matt Wallach, co-founder and president of Veeva Systems.  “The company’s disruptive solutions for data sourcing improve the cost and accuracy of many types of important healthcare initiatives.”

“With our new release of HealthVerity Marketplace, we are demonstrating the speed and efficiency with which our customers can build and license bespoke datasets that meet the demanding requirements of commercial analytics and real world evidence solutions,” said Andrew Kress, co-founder and chief executive officer of HealthVerity.  “We are grateful to Flare and Greycroft for their continued support of the company’s objective to transform the way data is made available for research, and to Foresite Capital for their new support.”

“HealthVerity Marketplace is achieving impressive traction with leading pharmaceutical companies who see the value in HealthVerity’s data access model,” said Michael Greeley, co-founder and partner at Flare Capital. “The company is changing the way early-adopter customers architect their healthcare data acquisition strategies by eliminating the barriers to accessing and developing insights across high value data assets.”

Ian Sigalow, co-founder and partner at Greycroft Partners said, “We are excited to be providing additional growth capital to HealthVerity as they build the industry’s most relevant ecosystem of healthcare data suppliers.  As new data types such as genomics rise in importance, the company’s partnering model enables suppliers to responsibly make their data interoperable and available for use in research and analytics in a privacy-compliant manner.”

Philadelphia, PA — April 21, 2016

HealthVerity, a leading provider of technologies and software tools for the discovery and integration of optimal patient data sets, today announced it has secured $7.1 million in Series A financing led by Flare Capital Partners and Greycroft Partners with participation from additional strategic healthcare investors. Additionally, Michael Greeley of Flare Capital, Rachel Winokur, an advisor to Greycroft, and Matt Wallach, co-founder and president of Veeva Systems, Inc., will join the company’s board of directors. HealthVerity will use the financing to fund continued development of its privacy and data interoperability technologies.

HealthVerity is developing an important set of proprietary technologies and software tools that enable its customers to rapidly discover, license and assemble patient data from a wide range of traditional and emerging healthcare data sources. The company’s solutions are proving to be critical to the success of Pharmaceutical, Hospital and Payer organizations that are seeking to enhance patient insights from existing and new data sources. “HealthVerity is focused on addressing the challenges of leading healthcare providers who are awash in clinical and transactional data, but who struggle to unlock the true value of their data assets,” said Andrew Kress, co-founder and chief executive officer of HealthVerity. “We are solving some very interesting next-generation problems that sit at the intersection of privacy and healthcare data management and access. Our solutions empower our customers to extract new insights with a more novel, intuitive and efficient approach to building data sets for research and analytics.”

“Healthcare providers are keenly aware of the power of complementing existing patient data with targeted third party sources. HealthVerity is demonstrating that cutting edge data science, extensive data provider relationships and unique market knowledge can bring important innovation to a critical segment of the healthcare industry,” said Michael Greeley, general partner at Flare Capital. “HealthVerity’s team has created the culture, technologies, tools, and infrastructure to succeed in this exciting endeavor.”

Ian Sigalow, co-founder and partner at Greycroft Partners said, “HealthVerity is shifting an industry by giving healthcare providers the technologies and software tools to discover new insights from previously siloed patient data. HealthVerity is very well positioned to take the lead in making this happen.”

“We are pleased by the significant interest in our Series A financing and are honored to have such a great group of financial and strategic investors to accelerate our progress,” said Kress.